A ngiotensin II (Ang II) is a major regulator of cardiovascular homeostasis. Its biological actions are mediated via 2 different types of G protein-coupled receptors, called AT 1 and AT 2 . 1 The AT 1 subtype mediates most of the cardiovascular actions, including vasoconstriction and aldosterone release. 2 Transgenic animals have been invaluable models to dissect the physiological role of individual components of the renin-angiotensin system. 3, 4 The contribution of the AT 2 subtype in cardiovascular regulation has remained elusive, although transgenic mouse models lacking or overexpressing this receptor have been generated. [5] [6] [7] Deletion of the gene encoding the AT 2 receptor in mice (AT 2 -KO mice) led to a phenotype with enhanced blood pressure sensitivity to Ang II, reduced exploratory behavior, and impaired drinking response after water deprivation. 5, 6 A growing body of evidence suggests that AT 1 and AT 2 elicit countervailing influences on cell growth (for review, see Reference 1) . The AT 2 receptor may exert an antigrowth effect on cells of the cardiovascular system and thus counteract the growth-promoting action of the AT 1 receptor. 8 -11 AT 2 receptors cause apoptosis in vascular smooth muscle cells (VSMCs). 12 Part of the growth-inhibitory effect of AT 2 receptor stimulation may be mediated by activation of phosphatases, which could attenuate several intracellular growth pathways (for review, see Nouet and Nahmias 13 ). On the basis of studies using pharmacological ligands, the role of AT 2 receptors in vascular remodeling in vivo is controversial. 14, 15 The regression of vascular hypertrophy is a potential therapeutic target for the reduction of complications associated with hypertension.
Here, we investigate whether deletion of the AT 2 receptor gene in mice leads to long-term functional or structural alterations in the cardiovascular system that might explain the increased pressure sensitivity of AT 2 -KO mice to Ang II infusion. Our studies show that hypertrophy of VSMCs is the structural basis for increased in vivo and in vitro responses to several vasoconstrictors, including Ang II and norepinephrine. Vascular hypertrophy in AT 2 -KO mice was associated with increased abundance of phosphorylated P70S6 kinase, which is a key regulator of protein synthesis and cell growth.
Methods

Generation and Genotyping of AT 2 Receptor-Deficient Mice
The generation of mice lacking functional AT 2 receptors has been described previously. 5 Germline-transmitting chimeric mice were crossed back onto an FVB/N background for 8 generations. For this study, only wild-type (WT) and hemizygous male littermates derived from crosses of male WT FVB/N mice and heterozygous AT 2 -KO mice were used (3 to 4 or 10 to 12 months old). One group of 4-week-old WT and AT 2 -KO mice was treated with the ACE inhibitor captopril for 8 weeks (1 mg/mL drinking water). All animal procedures were approved by the responsible university and government authorities (protocol No. 621-2531.01-10/98).
Cardiac Catheterization and Rapid MR Imaging
Under tribromoethanol anesthesia, a 1.8F high-fidelity catheter-tip micromanometer (Millar Instruments) was inserted via the right carotid artery into the aorta for arterial pressure measurements or into the left ventricle (LV) to assess cardiac contractility. 16 For acute blockade of AT 2 receptors, 30 mg/kg PD123319 was injected intravenously 15 minutes before infusion of Ang II, which was sufficient to block Ͼ98% of the AT 2 receptors in an ex vivo receptor-binding assay. For MRI of the heart, mice were anesthetized with isoflurane (2.0% isoflurane [vol/vol] in 1 L/min oxygen flow). Images of the heart were taken with a 7.05-T BIOSPEC 70/20 scanner. 17 
Isolated Blood Vessels
Vessels were placed in a physiological salt solution consisting of (mmol/L) NaCl 118, KCl 4.7, CaCl 2 2.5, MgSO 4 1.18, KH 2 PO 4 1.18, NaHCO 3 24.9, glucose 10, and EDTA 0.03 (37°C and 5% CO 2 /95% O 2 ). Two tungsten wires (40-m diameter) were threaded through the lumen of the vessel and mounted in a vessel myograph (Myo500, JPTrading). 18 Pre-tension of the vessels was set to 90% of the ID, which corresponded to an intraluminal pressure of 100 mm Hg. 18 
Histological Analysis
For morphometric analysis of the arterial vessels, mice were anesthetized with tribromoethanol and perfused with 4% glutaraldehyde in PBS at a pressure of 100 mm Hg through the apex of the LV. For histological investigation, the heart, aorta, kidney, and femoral and mesenteric arteries were embedded in paraffin or in epoxy resin. Cross sections and longitudinal sections were digitized with a Zeiss IM35 microscope, and morphometric analyses were performed with NIH Image and Adobe Photoshop software.
Plasma Renin-Angiotensin System
Plasma renin concentration and activity were determined as described previously. 19 Ang II concentrations were measured by radioimmunoassay, and ACE activity was determined by use of 10 mmol/L Z-Phe-His-Leu as substrate. 20 
Western Blotting
Frozen aortas from WT and AT 2 -KO mice were homogenized in 500 L lysis buffer (50 mmol/L Tris-HCl, 2% SDS, 1 mmol/L Na 3 VO 4 , pH 6.7). After addition of 10 L mercaptoethanol and 100 L benzonase (6%; Merck), samples were electrophoresed on 10% SDS-polyacrylamide gels and transferred onto nitrocellulose membranes (Millipore). Polyclonal antibodies were used to detect total levels of the respective kinase (ERK1/2, PKB/Akt, P70S6 kinase), and their phosphorylated forms were detected with phosphorylationspecific antibodies (Cell Signaling Technology). For controls, the expression of ␤-actin was determined (Sigma).
Statistical Analysis
The data displayed show meanϮSEM. For all experiments, 1-way or 2-way ANOVA tests followed by appropriate post hoc tests or t tests were used to determine statistical significance (PϽ0.05) with Prism 2.0 software (GraphPad).
Results
Cardiac Function of AT 2 Receptor-Knockout Mice
To assess the role of the AT 2 receptor in cardiovascular physiology, blood pressure, cardiac contractility, and vascular function were determined. In anesthetized mice, heart rate and maximal LV systolic pressure did not differ between AT 2 -KO and WT control mice (Figure 1a and 1b). Cardiac contractility was assessed by LV catheterization with a high-fidelity microtip catheter and by rapid MRI. Maximal LV contractility (dP/dt max ) and LV ejection fractions were not altered in AT 2 -KO mice compared with WT controls ( Figure  1c and 1d) . Thus, the deletion of the AT 2 receptor gene did not result in any detectable alteration of cardiac function in these mice.
Blood Pressure Regulation
To test the effects of vasoconstrictors on blood pressure regulation in AT 2 -KO mice, arterial pressure was measured in anesthetized mice. Under these conditions, baseline mean arterial pressure was similar in AT 2 -KO and WT mice ( Figure  2 ). This finding is consistent with the fact that no adaptive change in the activity of the circulating renin-angiotensin system could be detected in AT 2 -KO mice (Table 1) . We also could not detect alterations in AT 1 receptor mRNA or protein levels in the aorta from AT 2 -KO mice compared with WT specimens (data not shown). Small doses of Ang II led to a 
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Vascular Hypertrophy in AT 2 -KO Micesignificantly higher increase in blood pressure of AT 2 -KO mice than of WT controls (Figure 2a ). This finding is similar to the increased pressure sensitivity that has previously been reported in awake AT 2 -KO mice. 5, 6 The increased sensitivity to Ang II required genetic deletion of the AT 2 receptor gene, however, whereas acute pharmacological inhibition of the AT 2 receptor by the antagonist PD123319 in vivo did not alter the pressure effect of Ang II in WT mice (Figure 2b ). Taken together, these data suggest that the deletion of the AT 2 receptor gene exerted a long-term effect on the vascular system rather than an acute effect. This hypothesis could be further supported by the fact that acute infusion of the ␣ 1 -receptor agonist phenylephrine led to a significantly greater increase in diastolic and systolic blood pressure in AT 2 -KO mice than in WT mice (Figure 2c ).
Myograph Studies
To test whether the increased blood pressure sensitivity in AT 2 -KO mice was due to altered structure or function of the vasculature, we studied contractile responses of isolated femoral arteries in a small-vessel myograph. Ang II-induced active wall tension was 41% higher in vessel segments from AT 2 -KO mice than in those from WT mice (Figure 3a) . Similarly, activation of ␣ 1 -adrenergic receptors by norepinephrine led to higher wall tension in AT 2 -KO vessels than in WT vessels (Figure 3b) . Moreover, the vasoconstrictive effect of 120 mmol/L K ϩ depolarization was also increased in AT 2 -KO mice (Figure 3c ). Acetylcholine-induced vasorelaxation did not differ between WT and AT 2 -KO mice (E max WT 92Ϯ6% versus AT 2 -KO 97Ϯ2%, nϭ4), indicating unaltered endothelial function. These data suggest that the deletion of the AT 2 receptor gene led to a structural alteration of the vasculature, because both receptor-mediated and depolarization-induced vasoconstriction were enhanced in AT 2 -KO vessels. We thus tested whether vascular morphology was altered in mice lacking AT 2 receptors.
Vascular Morphology
In femoral arteries from the same location as that used for the myograph studies, a significant increase in media thickness and SMC size was apparent in AT 2 -KO vessels (Figure 4) . In contrast, intima and adventitia were not altered. A similar vascular phenotype was seen in small resistance arteries that supplied the thigh muscle ( Table 2 ). In these femoral resistance arteries, media cell cross-sectional area was increased by 82Ϯ15% in AT 2 -KO vessels. This increase was due to an increase in the cell size rather than in SMC number (Table 2) . Similarly, a significant enlargement of media myocytes was also observed in AT 2 -KO aortas (ϩ21Ϯ4%) and in renal resistance arteries (ϩ26Ϯ3%) but not in femoral veins.
Intracellular Signal Transduction
Ang II has been shown to regulate diverse intracellular signaling pathways. Using conventional and phosphorylationspecific antibodies, we tested the abundance and level of the phosphorylated form of the P70S6 kinase (phospho-P70S6), which has been shown to be associated with cell hypertrophy. In cell lysates from the aortas of AT 2 -KO mice, the signal detected with a phosphorylation-specific antibody for the P70S6 kinase was 65% greater in AT 2 -KO specimens than in WT control arteries (Figure 5a ). The abundance of P70S6 kinase was not elevated, and the ␤-actin signal used as a control was identical in AT 2 -KO and WT vessels. The enhanced phospho-P70S6 kinase level was specific for the arteries of AT 2 -KOs, because no alteration in phospho-P70S6 kinase could be detected in the heart (Figure 5b ). In addition, expression and phosphorylated levels of ERK1/2 kinase and Akt/PKB, 2 upstream activators of P70S6, were unchanged in the vasculature (Figure 5b ).
ACE Inhibition
To test whether vascular hypertrophy and increased P70S6 phosphorylation are causally linked in AT 2 -KO mice, animals were treated with the ACE inhibitor captopril for 8 weeks. ACE inhibition completely abolished the increased in vivo blood pressure responsiveness (Figure 6a and 6b) , attenuated the enhanced in vitro vasoconstriction (Figure 6c ) and phosphorylation of P70S6 kinase (Figure 6d) , and prevented vascular hypertrophy in AT 2 -KO mice (Figure 6e , crosssectional area of media SMCs 102Ϯ5% AT 2 -KO versus WT).
Discussion
Our studies demonstrate that Ang II AT 2 receptors may play an important role in vascular development. Mice lacking AT 2 receptors displayed a characteristic phenotype, with enhanced blood pressure sensitivity in vivo, increased vasoconstriction of isolated arteries, and hypertrophy of VSMCs. This phenotype was associated with an increased phosphorylation of the P70S6 kinase in the vascular wall and could be completely reversed by treatment with an ACE inhibitor. These data Expression of P70S6 kinase, ERK1/2, and Akt in aorta and heart of AT 2 -KO and WT mice. a, Abundance of P70S6 kinase was detected by conventional and phosphorylationspecific antibodies in aortic lysates. Signal for Thr421/Ser424-phosphorylated P70S6 kinase (phospho-P70S6) was increased by 65% in aorta from AT 2 -KO mice vs WT controls. Abundance of P70S6 protein and ␤-actin was unaltered. b, Levels of ERK1/2, phospho-ERK1/2, and phospho-Akt kinase in aorta and of phospho-P70S6 kinase in heart of AT 2 -KO and WT mice. Insets show representative blots from 4 to 6 independent experiments with 6 to 8 lanes per genotype. For these experiments, male mice 3 to 4 months old were used. *PϽ0.05.
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suggest that AT 2 receptors counterbalance the hypertrophic effects of the AT 1 receptor subtype in vivo by preventing activation of the P70S6 kinase. Several lines of evidence suggest that this phenotype is due to an imbalance of AT 1 and AT 2 receptor signaling in VSMCs rather than a general hypertrophic response of VSMCs to hypertension or increased activity of the renin-angiotensin system. Our strain of AT 2 -deficient mice did not show any evidence of increased blood pressure at baseline or of compensatory activation of the renin-angiotensin system. 5 AT 2 -KO mice generated on a C57BL6 inbred background, however, were found to be mildly hypertensive at rest. 6 Both strains of AT 2 -KO mice were more sensitive to the hypertensive effects of Ang II. In addition, we found that AT 2 -KO mice were more sensitive to stimulation with phenylephrine in vivo. The increased sensitivity was also found in isolated blood vessels in vitro. Ang II, norepinephrine, and K ϩ depolarization were found to cause stronger vasoconstriction in arteries from AT 2 -KO mice than in those from WT mice. At the age of 10 to 12 months, arterial SMCs from AT 2 -KO mice were hypertrophied compared with WT controls.
AT 2 receptors are abundantly expressed in VSMCs of the murine fetal vasculature during late gestation, when the blood vessels undergo remodeling. 9, 21 Ang II-induced growth in embryonic VSMCs from WT mice was increased by the AT 2 receptor antagonist PD123319, indicating that vascular AT 2 receptors are functional and exert an antigrowth effect in the normal mouse vasculature. Further evidence suggests that the AT 2 receptor promotes vascular differentiation and contributes to vasculogenesis in mice. 21, 22 Small amounts of AT 2 receptor could be detected in the aorta of WT mice by radioligand binding. 7, 23 In the rat, AT 2 receptors were expressed more abundantly in SMCs and endothelial cells from microvessels than in large vessels, suggesting that AT 2 receptors may be situated in a position in which they could directly oppose the effects of vascular AT 1 receptor activation. 24 The SMC hypertrophy in AT 2 -KO vessels was associated with an increased level of the phosphorylated form of P70S6 kinase (phospho-P70S6). It was previously demonstrated that Ang II can activate P70S6 kinase via AT 1 receptors in VSMCs and in cardiac myocytes. 25 This is the first report, however, to describe that AT 2 receptors may antagonize the effect of AT 1 receptors on P70S6 kinase activity in vivo. The mechanism by which AT 2 receptors mediate inhibition of P70S6 kinase activity remains unclear. Both ERK and PI3 kinase/Akt pathways have been implicated in activation of P70S6 in VSMCs. 26, 27 Neither phospho-ERK1/2 nor phospho-Akt/PKB levels were altered in AT 2 -KO aorta. AT 2 receptors can activate several intracellular phosphatases (for review see Reference 13), which might directly affect the phosphorylation status of P70S6 kinase. Identification of these phosphatases represents an important step to further identify the in vivo significance of the AT 2 receptor subtype.
It has been suggested that increased expression of AT 1 receptors alone may explain the AT 2 -KO phenotype, such as increased blood pressure, higher sensitivity to Ang II, and altered renal function. 23, 28 In the present mouse model, it is unlikely that the vascular phenotype is due to increased Ang II production or upregulation of AT 1 receptors, because we did not observe an increase of blood pressure, increased activity of the renin-angiotensin system, or upregulation of vascular AT 1 receptors. Thus, the vascular hypertrophy and increased levels of phospho-P70S6 kinase are most likely due to an imbalance in AT 1 versus AT 2 receptor signaling in VSMCs. This finding may have important pathophysiological relevance, because the long-term consequences of AT 2 receptor signaling for cardiovascular pathology are still unknown. These data suggest that inhibition of AT 2 receptors stimulates vascular hypertrophy and thus may be a prerequisite for development of overt hypertension. The role of AT 2 receptors may depend on the tissue, because in the heart, AT 2 is required for cardiac hypertrophy and inhibition of coronary artery remodeling after pressure overload by abdominal aortic constriction. 29, 30 These findings may have important clinical significance, because regression of hypertension-induced cardiac hypertrophy by AT 1 antagonists may be in part due to an unopposed antigrowth effect of Ang II mediated via AT 2 . Figure 6 . Treatment with ACE inhibitor captopril (8 weeks) abolished vascular hypertrophy and increased P70S6 kinase phosphorylation in AT 2 -KO mice. a and b, On intravenous infusion of ␣ 1 -adrenergic receptor agonist phenylephrine, systolic and diastolic arterial pressure increased to significantly higher levels in untreated AT 2 -KO mice than in WT mice. This difference between genotypes was abolished by ACE inhibitor treatment (nϭ6 to 8 mice per genotype). c, Maximal wall tension elicited by 120 mmol/L K ϩ or 30 mol/L norepinephrine did not differ between isolated femoral arteries from WT and AT 2 -KO mice, whereas response of AT 2 -KO vessels to 0.3 mol/L Ang II was increased (nϭ6 vessels per group). d, No difference was observed in levels of phospho-P70S6 kinase in aortic lysates (d) or in femoral artery structure (e) from WT and AT 2 -KO mice after ACE inhibitor therapy (nϭ4 mice per group). *PϽ0.05 AT 2 -KO vs WT.
